Condition: Acute MI · Heart Failure · Diabetes Mellitus · Sponsor: Aventyn, Inc.
The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.
This description comes directly from the study's public registry record.
Navin Govind Steering Committtee, MS · 2317942328 · info@aventyn.com
Aditya Vijay, MS · 2317942328
Always discuss trial participation with your own doctor first.
| Fountains Family Care | Chandler, Arizona, United States | Completed |
| Gilbert Cardiology | Gilbert, Arizona, United States | Recruiting |
| Arizona Heart Foundation | Phoenix, Arizona, United States | Recruiting |
| East Valley Diabetes | San Tan Valley, Arizona, United States | Completed |
| Karolinska University Hospital | Stockholm, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07403669